Stopping when knowing -use of snus and nicotine during pregnancy in Scandinavia
questionnaires, corrections were made upon the assumption that the 18-week questionnaire response overrode the 34-week questionnaire, with details given in the online supplement (table S2) .
Results
Overall, 35.7% of the 2350 women completing the 18-week questionnaire reported ever use of any type of snus or nicotine-containing products, with similar snus use and smoking rates. The significantly higher prevalence of nicotine use in Norway (37.4%) compared to Sweden (30.1%) (p=0.002), was predominantly related to ever use of snus in Norway (p=0.003).
In total 9.6% reported stopping snus use and 14.4% stopped smoking cigarettes years before pregnancy. In time before pregnancy, not specifically specified, overall 5.9% reported stopping use of snus and 3.3% stopping smoking cigarettes. There was a significantly higher prevalence in Norway (6.6%) compared to Sweden (3.4%) (p=0.005) for snus users stopping in time before pregnancy.
Of the 0.6% who reported current use of snus in pregnancy, nine women were daily users; two women used snus 3-5 times a week, and two less than once a week. Among the daily snus users the following categories were answered; three used 3-4 portions, four 5-6 portions and two more than 11 portions of snus a day.
Relapses after quitting snus or smoking in pregnancy was uncommon, with six (0.03%) relapsing to snus use and one to cigarette smoking between 18 and 34 weeks of pregnancy. Additionally one woman who used snus prior to becoming pregnant started using snus after 18 weeks, while two started cigarette smoking after 18 weeks pregnancy; one of them also used snus during pregnancy. Further details of the relapsing use were not obtained. The prevalence of snus, cigarette smoke or both stratified by country, based upon all 2350 women responding to the 18-week questionnaire. The percentages include use ever in life, stopped before pregnancy and use in pregnancy by 18 weeks. The prevalence of NRTs and e-cigarettes was low and not included in the figure. 
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Figure S2
The odds ratio (95% confidence interval) for reporting snus use at some time in pregnancy is given based upon area of living among 2350 women, adjusted for age, marital status, history of smoking, in-utero exposure to cigarette smoking by their mother and country of origin. The reference category was living in a village, and * indicates a p-value<0.05. 
